First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial
FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng…
Skin Cancer Awareness Month: Be Proactive, Reduce Your Risk
Skin cancer is the most commonly diagnosed cancer in the United States, but it is also a very preventable illness. Understand your risk and find out what steps you can take to keep your skin healthy year-round. More than 9,500…
The Bond Between Mother and Daughter: Kathy’s Story
The bond between a mother and child is a bond unlike any other. Mothers spend years sacrificing for their children, from sleepless nights to accepting that privacy and free time are foreign concepts to a mother. Nearly every mother, however,…
GBM AGILE – Changing the Way We Fight Brain Cancer
GBM survival rates have not improved in any meaningful way in over 30 years despite desperate efforts. Glioblastoma Multiforme, referred to simply as GBM, is the deadliest type of brain cancer. GBM is widely regarded as incurable and universally fatal,…
Treating Brain Cancer: What You Need to Know
Though the chance of developing brain cancer is quite rare, it is ranked as the tenth leading cause of death for both men and women. Despite being one of the most common cancers amongst children, brain cancer is relatively rare…
Stopping Melanoma in Its Tracks: Advancing Methods for Early Detection
Results of new study may offer researchers a more effective way to track the evolution of the most aggressive form of skin cancer. Although melanoma accounts for less than one percent of skin cancer cases, it is responsible for the…
